• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Tabula Rasa HealthCare Inc. (Amendment)

    6/28/22 5:14:59 PM ET
    $TRHC
    Business Services
    Consumer Discretionary
    Get the next $TRHC alert in real time by email
    SC 13D/A 1 d309089dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*

     

     

    TABULA RASA HEALTHCARE, INC.

    (Name of Issuer)

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

    873379101

    (CUSIP Number)

    David Maryles

    Managing Director, Legal and Compliance

    BlackRock, Inc.

    55 East 52nd Street

    New York, NY 10055

    (212) 810-5300

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    June 24, 2022

    (Date of Event which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box:  ☒

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No.: 873379101

     

      1    

      NAMES OF REPORTING PERSONS

     

      BlackRock, Inc.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      SOURCE OF FUNDS

     

      OO

      5  

      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2 (d) or 2(e)

     

      ☐

      6  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7     

      SOLE VOTING POWER

     

      512,228

         8   

      SHARED VOTING POWER

     

      0

         9   

      SOLE DISPOSITIVE POWER

     

      531,827

       10   

      SHARED DISPOSITIVE POWER

     

      0

    11    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      531,827

    12  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    13  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

      2.1%

    14  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      HC

     

    2


    EXPLANATORY NOTE

    This Amendment No. 2 (this “Amendment No. 2”) amends and supplements the Schedule 13D filed with the U.S. Securities and Exchange Commission on April 21, 2022, as amended by Amendment No. 1 filed June 21, 2022 (as amended the “Schedule 13D”), by and on behalf of BlackRock, Inc. (“BlackRock”), relating to the common stock, par value $0.0001 per share (the “Common Stock”), of Tabula Rasa HealthCare, Inc., a Delaware corporation (the “Issuer”).

    Except as specifically provided herein, this Amendment No. 2 does not modify any of the information previously reported on the Schedule 13D. Capitalized terms used but not otherwise defined in this Amendment No. 2 shall have the meanings ascribed to them in the Schedule 13D.

    Item 5. Interest in Securities of the Issuer.

    Items 5 (a)-(c) and (e) of the Schedule 13D are hereby amended and restated as follows:

    (a) and (b) The responses of BlackRock to Rows (7) through (11), and (13) of the cover page of this Schedule 13D are incorporated herein by reference.

    The aggregate percentage of shares of Common Stock reported as beneficially owned by BlackRock was calculated based on 25,849,263 shares of Common Stock issued and outstanding as of April 30, 2022, as disclosed in the Issuer’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, filed with the U.S. Securities and Exchange Commission on May 9, 2022.

    The Common Stock beneficially owned by BlackRock includes Common Stock beneficially owned by the Advisory Subsidiaries, including BlackRock Advisors, LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, National Association, BlackRock Financial Management, Inc., BlackRock Investment Management, LLC, BlackRock Investment Management (UK) Limited, Aperio Group, LLC and BlackRock (Netherlands) B.V., none of which individually beneficially owns in excess of 5% of the outstanding Common Stock.

    (c) Annex B, attached hereto, sets forth transactions in the Common Stock that were effected since the filing of Amendment No. 1 to the Schedule 13D. The transactions in the Common Stock described on Annex B were effected on securities exchanges unless otherwise indicated therein.

    (e) As of June 24, 2022, BlackRock no longer beneficially owns more than five percent of the Common Stock.


    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: June 28, 2022     BLACKROCK, INC.
        By:  

    /s/ David Maryles

        Name:   David Maryles
        Title:   Attorney in Fact


    Annex B

    Transaction in Common Stock

    Since Filing of Amendment No. 1 to the Schedule 13D

     

    Legal Entity

       Trade Date      Amount     Trade Price      Buy/Sell

    BlackRock Financial Management, Inc.

         6/17/2022        (1,528 )    $ 2.42      SELL

    BlackRock Fund Advisors

         6/17/2022        66     $ 2.42      BUY

    BlackRock Financial Management, Inc.

         6/17/2022        (5,507 )    $ 2.42      SELL

    BlackRock Fund Advisors

         6/17/2022        (240 )    $ 2.42      SELL

    BlackRock Fund Advisors

         6/17/2022        (1,530 )    $ 2.42      SELL

    BlackRock Fund Advisors

         6/17/2022        (1,955 )    $ 2.42      SELL

    BlackRock Fund Advisors

         6/17/2022        75     $ 2.42      BUY

    BlackRock Fund Advisors

         6/17/2022        (1,020 )    $ 2.42      SELL

    BlackRock Fund Advisors

         6/17/2022        798     $ 2.42      BUY

    BlackRock Fund Advisors

         6/17/2022        425     $ 2.42      BUY

    BlackRock Fund Advisors

         6/17/2022        2,550     $ 2.42      BUY

    BlackRock Fund Advisors

         6/17/2022        (720 )    $ 2.42      SELL

    BlackRock Fund Advisors

         6/17/2022        33     $ 2.42      BUY

    BlackRock Fund Advisors

         6/17/2022        54     $ 2.42      BUY

    BlackRock Fund Advisors

         6/17/2022        720     $ 2.42      BUY

    BlackRock Fund Advisors

         6/17/2022        (1,700 )    $ 2.42      SELL

    BlackRock Fund Advisors

         6/21/2022        (240 )    $ 3.09      SELL

    BlackRock Fund Advisors

         6/21/2022        (5,100 )    $ 3.09      SELL

    BlackRock Fund Advisors

         6/21/2022        30     $ 3.09      BUY

    BlackRock Financial Management, Inc.

         6/21/2022        35     $ 3.09      BUY

    BlackRock Fund Advisors

         6/21/2022        (850 )    $ 3.09      SELL

    BlackRock Fund Advisors

         6/21/2022        (850 )    $ 3.09      SELL

    BlackRock Fund Advisors

         6/21/2022        (765 )    $ 3.09      SELL

    BlackRock Fund Advisors

         6/21/2022        (240 )    $ 3.09      SELL

    BlackRock Fund Advisors

         6/22/2022        30     $ 2.96      BUY

    BlackRock Financial Management, Inc.

         6/22/2022        (10 )    $ 2.96      SELL

    BlackRock Fund Advisors

         6/22/2022        (1,700 )    $ 2.96      SELL


    Legal Entity

       Trade Date      Amount     Trade Price      Buy/Sell

    BlackRock Fund Advisors

         6/22/2022        595     $ 2.96      BUY

    BlackRock Fund Advisors

         6/22/2022        480     $ 2.96      BUY

    BlackRock Fund Advisors

         6/22/2022        (1,530 )    $ 2.96      SELL

    BlackRock Fund Advisors

         6/22/2022        765     $ 2.96      BUY

    BlackRock Financial Management, Inc.

         6/22/2022        1,618     $ 2.93      BUY

    BlackRock Fund Advisors

         6/22/2022        (720 )    $ 2.96      SELL

    BlackRock Fund Advisors

         6/22/2022        (1,200 )    $ 2.96      SELL

    BlackRock Fund Advisors

         6/22/2022        (170 )    $ 2.96      SELL

    BlackRock Fund Advisors

         6/22/2022        138     $ 2.96      BUY

    BlackRock Fund Advisors

         6/23/2022        480     $ 3.33      BUY

    BlackRock Fund Advisors

         6/23/2022        720     $ 3.33      BUY

    BlackRock Fund Advisors

         6/23/2022        (6,720 )    $ 3.33      SELL

    BlackRock Fund Advisors

         6/23/2022        1,020     $ 3.33      BUY

    BlackRock Fund Advisors

         6/23/2022        255     $ 3.33      BUY

    BlackRock Fund Advisors

         6/23/2022        (510 )    $ 3.33      SELL

    BlackRock Advisors, LLC

         6/24/2022        (1,878 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (352 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (531 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (23 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (4,430 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        4,305     $ 3.23      BUY

    BlackRock Investment Management, LLC

         6/24/2022        (29,490 )    $ 3.23      SELL

    BlackRock Financial Management, Inc.

         6/24/2022        14,233     $ 3.23      BUY

    BlackRock Financial Management, Inc.

         6/24/2022        (38 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (157 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (91 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (71 )    $ 3.23      SELL

    BlackRock Financial Management, Inc.

         6/24/2022        (825 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (3,472 )    $ 3.23      SELL


    Legal Entity

       Trade Date      Amount     Trade Price      Buy/Sell

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (80,362 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (1,553 )    $ 3.23      SELL

    BlackRock Fund Advisors

         6/24/2022        48     $ 3.23      BUY

    BlackRock Investment Management, LLC

         6/24/2022        (1,626 )    $ 3.23      SELL

    BlackRock Advisors, LLC

         6/24/2022        (1,212 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (242 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (1,812 )    $ 3.23      SELL

    BlackRock Fund Advisors

         6/24/2022        49,412     $ 3.23      BUY

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (167 )    $ 3.23      SELL

    BlackRock Financial Management, Inc.

         6/24/2022        (9,871 )    $ 3.23      SELL

    BlackRock Advisors, LLC

         6/24/2022        (8,725 )    $ 3.23      SELL

    BlackRock Financial Management, Inc.

         6/24/2022        (361 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (191 )    $ 3.23      SELL

    BlackRock Financial Management, Inc.

         6/24/2022        (249 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (2,056 )    $ 3.23      SELL

    BlackRock Financial Management, Inc.

         6/24/2022        (271 )    $ 3.23      SELL

    BlackRock Advisors, LLC

         6/24/2022        (1,489 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (735 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (1,274 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (2,536 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (254 )    $ 3.23      SELL

    BlackRock Financial Management, Inc.

         6/24/2022        (2 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (1,288 )    $ 3.23      SELL

    BlackRock Financial Management, Inc.

         6/24/2022        (32 )    $ 3.23      SELL

    BlackRock Fund Advisors

         6/24/2022        24     $ 3.23      BUY

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (140 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (35,923 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (234 )    $ 3.23      SELL

    BlackRock Fund Advisors

         6/24/2022        (26,988 )    $ 3.23      SELL


    Legal Entity

       Trade Date      Amount     Trade Price      Buy/Sell

    BlackRock Advisors, LLC

         6/24/2022        (2,751 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (80 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (32,869 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (3,546 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (6,376 )    $ 3.23      SELL

    BlackRock Fund Advisors

         6/24/2022        (489,541 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (3,030 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (414 )    $ 3.23      SELL

    BlackRock Financial Management, Inc.

         6/24/2022        (4,921 )    $ 3.23      SELL

    BlackRock Fund Advisors

         6/24/2022        (10,545 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (70 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (1,980 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (332 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (1,060 )    $ 3.23      SELL

    BlackRock Advisors, LLC

         6/24/2022        17,533     $ 3.23      BUY

    BlackRock Investment Management, LLC

         6/24/2022        (113 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (4,387 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (87 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (1,448 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (13,337 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (1,586 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (195 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (13 )    $ 3.23      SELL

    BlackRock Advisors, LLC

         6/24/2022        (34,073 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        (5 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (361 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (6,505 )    $ 3.23      SELL

    BlackRock Financial Management, Inc.

         6/24/2022        (4,519 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (2,840 )    $ 3.23      SELL

    BlackRock Institutional Trust Company, National Association

         6/24/2022        15,528     $ 3.23      BUY

    BlackRock Investment Management, LLC

         6/24/2022        (6,021 )    $ 3.23      SELL

    BlackRock Financial Management, Inc.

         6/24/2022        (544 )    $ 3.23      SELL

    BlackRock Fund Advisors

         6/24/2022        (191,269 )    $ 3.23      SELL

    BlackRock Investment Management, LLC

         6/24/2022        (58 )    $ 3.23      SELL
    Get the next $TRHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TRHC

    DatePrice TargetRatingAnalyst
    5/10/2023$7.00 → $10.00Market Perform → Outperform
    SVB Securities
    3/2/2022$30.00 → $15.00Buy
    Benchmark
    2/28/2022$23.00 → $11.00Market Perform
    SVB Leerink
    2/1/2022$24.00 → $11.00Outperform → Neutral
    Robert W. Baird
    2/1/2022$24.00 → $11.00Outperform → Neutral
    Baird
    12/2/2021$13.00Hold
    Jefferies
    11/8/2021$70.00 → $23.00Outperform
    RBC Capital
    11/8/2021$40.00 → $23.00Market Perform
    SVB Leerink
    More analyst ratings

    $TRHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Lifshitz Law PLLC Announces Investigations of VRTV, FRGI, TRHC, and SOVO

      NEW YORK, Aug. 12, 2023 (GLOBE NEWSWIRE) -- Veritiv Corporation (NYSE:VRTV) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of VRTV to an affiliate of Clayton, Dubilier & Rice, LCC for $170.00 per share in cash for each share of VRTV common stock owned. If you are a VRTV investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected]. Fiesta Restaurant Group, Inc. (NASDAQ:FRGI) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary dutie

      8/12/23 8:17:00 PM ET
      $FRGI
      $SOVO
      $TRHC
      $VRTV
      Restaurants
      Consumer Discretionary
      Packaged Foods
      Consumer Staples
    • Tabula Rasa HealthCare Reports Second Quarter 2023 Financial Results

      Continued Strong Organic Revenue Growth of 24% Second Quarter Adjusted EBITDA of $6.3 Million Increased More Than 3x Compared to Second Quarter 2022 MOORESTOWN, N.J., Aug. 7, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC) ("TRHC" or the "Company"), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today reported financial results for the second quarter ended June 30, 2023. Highlights from the second quarter ended June 30, 2023 include: Second quarter revenue from continuing operations of $90.0 million

      8/7/23 7:02:00 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Tabula Rasa and ExactCare to Combine to Create a Leading, Independent Pharmacy Care Management Company That Services Patients with the Most Complex Needs

      $10.50 Per Share All-Cash Transaction Represents a Significant Premium for Tabula Rasa Stockholders Combination of Two Highly Complementary Companies to Benefit Patients, Providers and Payers with First of its Kind Risk Management Platform in Pharmacy Care Expands the Reach of Tabula Rasa's MedWise Technology Platform to Multiple Provider and Payer Markets MOORESTOWN, N.J., Aug. 7, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® ("TRHC," "Tabula Rasa" or the "Company") (NASDAQ:TRHC), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today announced it has entered into a definitive agreement (the "Agreement") to be acquired by Nauti

      8/7/23 7:00:00 AM ET
      $TRHC
      Business Services
      Consumer Discretionary

    $TRHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Tabula Rasa HealthCare Inc. (Amendment)

      SC 13D/A - Tabula Rasa HealthCare, Inc. (0001651561) (Subject)

      8/8/23 4:01:33 PM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Tabula Rasa HealthCare Inc. (Amendment)

      SC 13G/A - Tabula Rasa HealthCare, Inc. (0001651561) (Subject)

      2/9/23 11:35:13 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Tabula Rasa HealthCare Inc. (Amendment)

      SC 13D/A - Tabula Rasa HealthCare, Inc. (0001651561) (Subject)

      9/14/22 3:21:21 PM ET
      $TRHC
      Business Services
      Consumer Discretionary

    $TRHC
    SEC Filings

    See more
    • SEC Form EFFECT filed by Tabula Rasa HealthCare Inc.

      EFFECT - Tabula Rasa HealthCare, Inc. (0001651561) (Filer)

      11/17/23 12:15:07 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • SEC Form EFFECT filed by Tabula Rasa HealthCare Inc.

      EFFECT - Tabula Rasa HealthCare, Inc. (0001651561) (Filer)

      11/17/23 12:15:26 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • SEC Form EFFECT filed by Tabula Rasa HealthCare Inc.

      EFFECT - Tabula Rasa HealthCare, Inc. (0001651561) (Filer)

      11/17/23 12:15:13 AM ET
      $TRHC
      Business Services
      Consumer Discretionary

    $TRHC
    Leadership Updates

    Live Leadership Updates

    See more
    • Tabula Rasa HealthCare Provides Corporate Updates

      Appoints Brian Adams as President and Chief Executive Officer and a Member of the Board of Directors, Effective Immediately Appoints Richard W. Rew II as Chief Legal Officer and Corporate Secretary Announces Preliminary Unaudited First Quarter 2023 Revenue Exceeding Guidance MOORESTOWN, N.J., April 13, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC) ("TRHC" or the "Company"), a leading healthcare technology company advancing the safe use of medications, today announced the appointment of Brian Adams as President and Chief Executive Officer. Mr. Adams, who was serving as TRHC's interim Chief Executive Officer since September 2022 and previously served as the Company's Co-Pre

      4/13/23 4:05:00 PM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Tabula Rasa HealthCare Names April Gill Chief Commercial Officer

      MOORESTOWN, N.J., Nov. 1, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, today announced the appointment of April D. Gill as Chief Commercial Officer. Ms. Gill has more than 20 years of experience in healthcare with a proven track record exceeding client satisfaction, sales, and profitability goals. In this newly created role, Ms. Gill will oversee development and execution of TRHC's commercialization with broad responsibility for strategy, product, marketing, communication

      11/1/22 8:30:00 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Tabula Rasa HealthCare Announces Leadership Transition

      Drs. Calvin H. Knowlton and Orsula V. Knowlton to retire from the Company Co-President Brian Adams Named Interim CEO Director Michael Purcell Named Independent Board Chairman MOORESTOWN, N.J., Sept. 14, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, today announced that co-founders Dr. Calvin H. Knowlton, BScPharm, MDiv, PhD, ScD (hon), Chief Executive Officer and Board Chairman, and Dr. Orsula V. Knowlton, PharmD, MBA, Co-President and Chief Marketing and New Business Development Officer, will retire from TRHC and step down as members of the Board of Directors, effective immediately. Dir

      9/14/22 8:00:00 AM ET
      $TRHC
      Business Services
      Consumer Discretionary

    $TRHC
    Financials

    Live finance-specific insights

    See more
    • Tabula Rasa HealthCare Reports Second Quarter 2023 Financial Results

      Continued Strong Organic Revenue Growth of 24% Second Quarter Adjusted EBITDA of $6.3 Million Increased More Than 3x Compared to Second Quarter 2022 MOORESTOWN, N.J., Aug. 7, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC) ("TRHC" or the "Company"), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today reported financial results for the second quarter ended June 30, 2023. Highlights from the second quarter ended June 30, 2023 include: Second quarter revenue from continuing operations of $90.0 million

      8/7/23 7:02:00 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Tabula Rasa HealthCare Schedules Second Quarter 2023 Earnings Conference Call

      MOORESTOWN, N.J., July 25, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its second quarter 2023 financial results Tuesday, August 8, 2023 at 8:30 a.m. EDT. The Company's financial results for the second quarter 2023 ended June 30, 2023, will be released after the close of the market Monday, August 7, 2023. Those interested in participating via webcast in listen-only mode can access the event here. For participants who would like to participate via telephone, please register here to receive the dial-in numbe

      7/25/23 4:30:00 PM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Tabula Rasa HealthCare Reports First Quarter 2023 Financial Results

      First Quarter Results Show Benefits of Consistent Execution on Financial and Strategic Objectives First Quarter Revenue Growth of 32% Compared to First Quarter 2022 Raises Full Year 2023 Revenue and Adjusted EBITDA Guidance MOORESTOWN, N.J., May 8, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC) ("TRHC" or the "Company"), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the first quarter ended March 31, 2023. Highlights from the first quarter ended March 31, 2023, include: First quarter revenu

      5/8/23 4:30:00 PM ET
      $TRHC
      Business Services
      Consumer Discretionary

    $TRHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Tabula Rasa HealthCare upgraded by SVB Securities with a new price target

      SVB Securities upgraded Tabula Rasa HealthCare from Market Perform to Outperform and set a new price target of $10.00 from $7.00 previously

      5/10/23 6:30:40 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Benchmark reiterated coverage on Tabula Rasa HealthCare with a new price target

      Benchmark reiterated coverage of Tabula Rasa HealthCare with a rating of Buy and set a new price target of $15.00 from $30.00 previously

      3/2/22 7:40:57 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • SVB Leerink reiterated coverage on Tabula Rasa HealthCare with a new price target

      SVB Leerink reiterated coverage of Tabula Rasa HealthCare with a rating of Market Perform and set a new price target of $11.00 from $23.00 previously

      2/28/22 4:58:06 AM ET
      $TRHC
      Business Services
      Consumer Discretionary

    $TRHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Mitchell Ronald Paul returned 79,332 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Tabula Rasa HealthCare, Inc. (0001651561) (Issuer)

      11/14/23 9:09:01 PM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Purcell Michael J. returned 139,322 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Tabula Rasa HealthCare, Inc. (0001651561) (Issuer)

      11/14/23 9:02:19 PM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Schwartz Jonathan David returned 78,388 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Tabula Rasa HealthCare, Inc. (0001651561) (Issuer)

      11/14/23 8:59:36 PM ET
      $TRHC
      Business Services
      Consumer Discretionary